Literature DB >> 6534896

d-Fenfluramine selectively decreases carbohydrate but not protein intake in obese subjects.

J J Wurtman, R J Wurtman.   

Abstract

Studies on normal rats and on obese human subjects exhibiting 'carbohydrate-craving' suggest that brain mechanisms exist allowing appetites for carbohydrates and proteins to be regulated independent of those for calories and for tastes of the carbohydrates. We observe that virtually all of the excess in daily energy intake among these obese people can be accounted for by carbohydrate snacks, and that a serotonin-releasing drug, d-fenfluramine, selectively diminishes the tendency to consume these snacks.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6534896

Source DB:  PubMed          Journal:  Int J Obes


  7 in total

Review 1.  Dexfenfluramine. Its place in weight control.

Authors:  P Turner
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 2.  The role of serotonin in eating disorders.

Authors:  S F Leibowitz
Journal:  Drugs       Date:  1990       Impact factor: 9.546

3.  Stimulation of 5-hydroxytryptamine nerve cells in dorsal and median raphe nuclei elevates blood glucose in rats.

Authors:  M T Lin; L R Shian
Journal:  Pflugers Arch       Date:  1991-01       Impact factor: 3.657

Review 4.  Dexfenfluramine. An updated review of its therapeutic use in the management of obesity.

Authors:  R Davis; D Faulds
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

Review 5.  Dexfenfluramine. A review of its pharmacological properties and therapeutic potential in obesity.

Authors:  D McTavish; R C Heel
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

6.  Serotonin transporter gene promoter polymorphism is associated with body mass index and obesity in non-elderly stroke patients.

Authors:  M Y Lan; Y Y Chang; W H Chen; Y F Kao; H S Lin; J S Liu
Journal:  J Endocrinol Invest       Date:  2009-02       Impact factor: 4.256

7.  Production and Characterization of a New α-Glucosidase Inhibitory Peptide from Aspergillus oryzae N159-1.

Authors:  Min-Gu Kang; Sung-Hun Yi; Jong-Soo Lee
Journal:  Mycobiology       Date:  2013-09-30       Impact factor: 1.858

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.